Resultados de búsqueda - Denis Moro‐Sibilot

Limitar resultados
  1. 1
    First- and second-line therapy for advanced nonsmall cell lung cancer

    First- and second-line therapy for advanced nonsmall cell lung cancer por Sculier Jp, Denis Moro‐Sibilot

    Publicado 2009
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib

    Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib por Oana Lelia Pop, Augustin Pirvu, Anne‐Claire Toffart, Denis Moro‐Sibilot

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer

    Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer por Denis Moro‐Sibilot, Axel Aubert, Sami Diab, Sylvie Lantuéjoul, P. Fourneret, E. Brambilla, Christian Brambilla, Pierre-Yves Brichon

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer

    Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer por Arnaud Van Den Broeck, Élisabeth Brambilla, Denis Moro‐Sibilot, Sylvie Lantuéjoul, Christian Brambilla, Béatrice Eymin, Saadi Khochbin, Sylvie Gazzéri

    Publicado 2008
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Early detection of lung cancer: role of biomarkers

    Early detection of lung cancer: role of biomarkers por Christian Brambilla, Frédéric Fievet, M. Jeanmart, Florence de Fraipont, Sylvie Lantuéjoul, V. Frappat, G. Ferretti, Pierre-Yves Brichon, Denis Moro‐Sibilot

    Publicado 2003
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  6. 6
    Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis

    Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis por Denis Moro‐Sibilot, Sylvie Lantuéjoul, Sami Diab, Nabila Moulaï, Axel Aubert, J. F. Timsit, Christian Brambilla, Pierre-Yves Brichon, E. Brambilla

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study

    Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study por Anne McLeer‐Florin, Denis Moro‐Sibilot, A. Melis, Dimitri Salameire, Christine Lefebvre, Françoise Ceccaldi, Florence de Fraipont, Élisabeth Brambilla, Sylvie Lantuéjoul

    Publicado 2011
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours

    Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours por Sylvie Lantuéjoul, Jean‐Charles Soria, Denis Moro‐Sibilot, Luc Morat, Sylvie Veyrenc, P. Lorimier, Pierre-Yves Brichon, Laure Sabatier, Christian Brambilla, Élisabeth Brambilla

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype

    IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype por J. Cadranel, Élisabeth Quoix, Laurence Baudrin, Pierre Mourlanette, Denis Moro‐Sibilot, Jean‐François Morère, Pierre-Jean Souquet, Jean‐Charles Soria, Franck Morin, B. Milleron

    Publicado 2009
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

    Circulating free DNA concentration is an independent prognostic biomarker in lung cancer por Claire Tissot, Anne‐Claire Toffart, Stéphanie Villar, Pierre-Jean Souquet, P. Merle, Denis Moro‐Sibilot, M. Pérol, Jiří Zavadil, Christian Brambilla, Magali Olivier, S. Couraud

    Publicado 2015
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Prognostic Impact of Paraneoplastic Cushing’s Syndrome in Small-Cell Lung Cancer

    Prognostic Impact of Paraneoplastic Cushing’s Syndrome in Small-Cell Lung Cancer por Hélène Nagy-Mignotte, Oxana Shestaeva, Lucile Vignoud, Pascale Guillem, Stéphane Ruckly, Olivier Chabre, L. Sakhri, M. Duruisseaux, Mireille Mousseau, Jean‐François Timsit, Denis Moro‐Sibilot

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    <i>MET</i> exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

    <i>MET</i> exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung por Raphaël Saffroy, Vincent Fallet, Nicolas Girard, Julien Mazières, Denis Moro‐Sibilot, Sylvie Lantuéjoul, Isabelle Rouquette, Françoise Thivolet-Béjui, Thibaut Vieira, Martine Antoine, Jacques Cadranel, Antoinette Lemoine, Marie Wislez

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas

    On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas por Lénaïg Mescam-Mancini, Sylvie Lantuéjoul, Denis Moro‐Sibilot, Isabelle Rouquette, Pierre-Jean Souquet, Clarisse Audigier-Valette, Jean‐Christophe Sabourin, C. Decroisette, L. Sakhri, Élisabeth Brambilla, Anne McLeer‐Florin

    Publicado 2013
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

    CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients por J-L. Pujol, Olivier Molinier, W. Ébert, Daurès Jp, Fabrice Barlési, G Buccheri, M Paesmans, Élisabeth Quoix, Denis Moro‐Sibilot, M Szturmowicz, J-M Bréchot, T. Muley, Jean‐Christophe Grenier

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  15. 15
    Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity

    Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity por Christian Brambilla, Julien Laffaire, Sylvie Lantuéjoul, Denis Moro‐Sibilot, Hélène Mignotte, François Arbib, Anne‐Claire Toffart, Fabien Petel, Pierre Hainaut, Sophie Rousseaux, Saadi Khochbin, Aurélien de Reyniès, Élisabeth Brambilla

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus

    Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus por Federico Cappuzzo, Denis Moro‐Sibilot, Oliver Gautschi, Ekaterini Boleti, Enriqueta Felip, Harry J.M. Groen, Paul Germonpré, Peter Meldgaard, Edurne Arriola, N. Steele, J. Fox, Patrick Schnell, Arne Engelsberg, Jürgen Wolf

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  17. 17
    Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival

    Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival por E. Pluquet, J. Cadranel, Anne Legendre, Michelle Beau Faller, Pierre Jean Souquet, Gérard Zalcman, M. Pérol, G. Fraboulet, Gerard Oliveiro, Florence de Fraipont, Élisabeth Quoix, Sylvie Lantuéjoul, B. Milleron, Denis Moro‐Sibilot

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets

    High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets por Vincent Fallet, Raphaël Saffroy, Nicolas Girard, Julien Mazières, Sylvie Lantuéjoul, T. Vieira, Isabelle Rouquette, F. Thivolet-Béjui, Mony Ung, Virginie Poulot, L. Schlick, Denis Moro‐Sibilot, Martine Antoine, Jacques Cadranel, Antoinette Lemoine, Marie Wislez

    Publicado 2015
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics

    A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics por Léonie Ferrer, Matteo Giaj Levra, Marie Brevet, Martine Antoine, Julien Mazières, Giulio Rossi, Rita Chiari, Virginie Westeel, M. Poudenx, J. Letreut, Radj Gervais, Giorgia Osman, Nicolas Girard, Anne Claire Toffart, Silvia Novello, Denis Moro‐Sibilot

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non–Small-Cell Lung Cancer

    Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non–Small-Cell Lung Cancer por Stéphane Vignot, Garrett M. Frampton, Jean‐Charles Soria, Roman Yelensky, Frédéric Commo, Christian Brambilla, Gary A. Palmer, Denis Moro‐Sibilot, Jeffrey S. Ross, Maureen Cronin, Fabrice André, Philip J. Stephens, Vladimir Lazar, Vincent A. Miller, Élisabeth Brambilla

    Publicado 2013
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: